Kybella Deoxycholic Acid Fat Reduction

Kybella (deoxycholic acid) injections at Wall Street Dermatology to permanently destroy submental fat cells for double chin reduction, as well as off-label treatment of bra fat, abdomen, legs, and buttocks. FDA-approved for the submental area. Sessions take 15–20 minutes. Typically 2–4 sessions are needed, spaced at least one month apart. Priced from $1,700–$2,000 for the chin area.

Wall Street Dermatology offers Kybella (ATX-101, deoxycholic acid) injections as a non-surgical fat reduction treatment for the submental area and off-label body sites. Deoxycholic acid is a naturally occurring bile acid produced by the body to assist in the emulsification and absorption of dietary fats; as an injectable formulation, it works by disrupting the cell membrane of adipocytes at the injection site, causing cell lysis and permanent destruction of the fat cells. The lysed adipocytes are then cleared by the body's inflammatory response over the weeks following treatment, with the final result apparent at 4–6 weeks post-injection. Because the fat cells are permanently destroyed and do not regenerate, the reduction achieved is considered long-lasting provided the patient does not gain significant weight. The FDA has approved Kybella specifically for the submental (under-chin, double chin) area, and Dr. Tzu uses it for this primary indication at prices of $1,700–$2,000 per session. Off-label use at the clinic includes the upper arms and bra fat area (the axillary fat roll adjacent to the bra band), priced at $2,000 per session, and the abdomen, leg, or buttock localised fat deposits at $2,000–$3,500 per session. Sessions run 15–20 minutes. Post-treatment swelling, tenderness, and redness in the treated area are common and reflect the expected inflammatory fat-clearing response; this can be pronounced and last 2–4 weeks with submental treatment. Typically 2–4 sessions are required for the desired result, with up to 6 sessions permissible. Sessions are spaced at minimum one month apart to allow resolution of the inflammatory response before the next treatment.